In our large Endomechanical business, stapling products continued to perform very well with a double-digit increase led by the innovative Tri-Staple reloads. We experienced a strong demand for Tri-Staple as we continue to grow above the market and gain incremental share in stapling.
Covidien Management Discusses Q3 2012 Results - Earnings Call Transcript
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts